Portal de Periódicos da CAPES

Approach to the discovery of novel, selective inhibitors of p56 lck tyrosine kinase: Identification of non‐hydroxylated chromones as p56 lck inhibitors

1995; Wiley; Volume: 34; Issue: 4 Linguagem: Inglês

10.1002/ddr.430340406

1098-2299

Deborah Miller, Su Wang, John Reid, Wen Xie, Bruce Gauvin, Marian Kelley, Jay Sarup, David G. Sawutz, Mahmut Miski, Roland E. Dolle, Connie R. Faltynek,

HER2/EGFR in Cancer Research

Abstract The protein tyrosine kinase p56 Ick , which is expressed predominantly in lymphocytes, plays a critical role in optimal T cell activation through the T cell antigen receptor. An approach is presented for the discovery of selective p56 Ick inhibitors, which are potential immunosuppressants. A non‐radioactive assay for p56 Ick tyrosine kinase activity has been developed and adapted for high volume screening. This assay does not require purified enzyme. p56 Ick in the plasma membranes of a human T cell line is purified in situ by immobilization onto the wells of a microtiter plate using an antibody specific for p56 Ick . Following the kinase reaction in the presence of test compound, autophosphorylated p56 Ick is detected with a biotinylated monoclonal antibody to phosphotyrosine. Using the approach described in this report, three simple chromones have been identified that inhibit p56 Ick autophosphorylation with low micromolar potencies and exhibit some selectivity for p56 Ick over the serine/threonine and other tyrosine kinases tested. These compounds constitute a novel group of p56 Ick tyrosine kinase inhibitors. ©1995 Wiley‐Liss, Inc.